Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation
Rama Krishna Kancha, Nikolas Von Bubnoff, Cornelius Miething, Christian Peschel, Katharina S. Götze, Justus Duyster*
*Korrespondierende/r Autor/-in für diese Arbeit
20
Link öffnet neuen Tab
Zitate (Scopus)